Lili Reinhart’s Year of Misdiagnosis: How Endometriosis, Adenomyosis and Bladder Pain Slip Through the Medical Net

Key Highlights:
Introduction
When a "UTI" Is Not a UTI: How Symptoms Overlap and Mislead
Bladder Pain Syndrome, Pelvic Floor Dysfunction and the Diagnostic Shadow
Endometriosis and Adenomyosis: Closely Related, Often Overlooked
The Role and Limits of Imaging and Cystoscopy
Conservative Treatments: Where They Help and Where They Fall Short
Diagnostic Laparoscopy and Excision: Confirmation and Treatment
Fertility, Hormonal Choices and Tough Trade-offs
The Emotional and Psychological Toll
Structural Failures: Why Diagnosis Is Delayed
Practical Strategies for Patients: How to Advocate and Where to Look
What Clinicians Should Change: Diagnostic Rigor and Respectful Care
Outcomes and Uncertainties: What Patients Can Expect After Treatment
Research and Future Directions
The Cultural Dimension: Pain, Visibility and the Momentum for Change
Putting It Together: A Roadmap for Patients and Providers
FAQ

Key Highlights:

A public figure’s prolonged search for answers exposes common diagnostic gaps: UTIs and bladder pain are frequently misattributed, while endometriosis and adenomyosis remain under-recognized causes of pelvic and urinary symptoms.
Multidisciplinary evaluation—including pelvic floor therapy, targeted imaging, cystoscopy, and diagnostic laparoscopy with excision—remains the most reliable pathway to diagnosis and meaningful symptom relief.
Structural problems in care delivery—dismissal of women’s pain, fragmented specialty care, and uneven access to experienced surgeons—drive diagnostic delays and emotional harm; clear strategies exist for patients and clinicians to shorten that path.

Introduction

A string of urinary urgency episodes that began as what seemed like a routine urinary tract infection escalated into a year-long diagnostic odyssey for an otherwise healthy woman. She endured repeated negative urine cultures, multiple courses of antibiotics, bladder instillations, pelvic floor therapy, MRI findings suggesting adenomyosis, and finally underwent laparoscopic surgery that confirmed endometriosis and adenomyosis. The experience left her not only physically recovering but also grappling with the psychological fallout of being disbelieved, and with hard questions about future fertility and chronic pain management.

That case—recently recounted in a personal essay—crystallizes a pattern seen throughout gynecology and urology: overlapping pelvic conditions masquerade as more common problems, tests come back normal, and patients are bounced from specialty to specialty before arriving at a correct diagnosis. The consequences are wasted time, unnecessary treatments, avoidable suffering, and rising mistrust in the system. What follows unpacks that journey, explains the science behind the conditions involved, analyzes why the system fails so often, and outlines practical steps patients and clinicians can take to shorten the road to diagnosis and appropriate care.

When a "UTI" Is Not a UTI: How Symptoms Overlap and Mislead

Urinary urgency, frequency, and pelvic pain are hallmark complaints for primary care and emergency departments. Most clinicians are trained to treat a suspected urinary tract infection (UTI) promptly. The problem begins when symptoms persist despite standard therapy.

Persistent urinary symptoms fall into several common categories:

Recurrent or resistant bacterial cystitis.
Bladder pain syndrome/interstitial cystitis (BPS/IC).
Pelvic floor dysfunction and myofascial pain.
Gynecologic causes: endometriosis or adenomyosis impinging on the bladder or pelvic nerves.
Neurologic causes or systemic inflammatory disorders.

A standard urine dip or culture will catch many bacterial infections, but not conditions like BPS/IC or endometriosis. That distinction is critical because repeated antibiotic courses and negative cultures can both delay the search for alternative explanations and harm the patient’s microbiome and overall health.

The patient narrative at the center of this article begins with an episode that was managed as a mild infection abroad. When cultures later returned negative, the clinical momentum shifted—incorrectly—for months. This is a familiar scenario. Women with pelvic and urinary complaints frequently report being treated for infection first and told their tests are normal later, even as symptoms continue. The palpable discomfort becomes dismissed as psychosomatic or anxiety-driven, especially when objective tests are “clean.” The result is both diagnostic confusion and the emotional weight of having one's pain minimized.

Bladder Pain Syndrome, Pelvic Floor Dysfunction and the Diagnostic Shadow

When urine cultures are negative but symptoms persist, clinicians and patients enter the diagnostic shadowland where bladder pain syndrome (also called interstitial cystitis) and pelvic floor dysfunction are common considerations.

Bladder pain syndrome is a chronic bladder condition characterized by persistent bladder pressure and pelvic pain, often accompanied by urinary urgency and frequency. It can include discrete findings—such as Hunner lesions visible on cystoscopy—but many patients have no clearly visible bladder pathology. Management ranges from bladder instillations and oral medications to behavioral strategies and neuromodulation.

Pelvic floor dysfunction occurs when muscles that support the pelvic organs are too tight, poorly coordinated, or painful. Rather than being weak, these muscles may chronically contract in response to pain, injury, or nerve irritation. That tightening can intensify urinary urgency and frequency and can be a primary pain generator or a secondary response to another pelvic pathology. Pelvic floor physical therapy—techniques to release, retrain, and relax those muscles—is a mainstay of treatment and can provide meaningful symptom relief even when no other disorder is found.

In the case under discussion, pelvic floor therapy brought intermittent relief for days at a time. That pattern—temporary but measurable improvement after targeted physical therapy—often points clinicians toward a neuromuscular component to symptoms and should prompt further gynecologic and urologic evaluation rather than becoming the endpoint of care.

Endometriosis and Adenomyosis: Closely Related, Often Overlooked

Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus: on ovaries, the pelvic peritoneum, bowel, or other structures. It causes chronic inflammation, scar tissue, pelvic pain, and can impair fertility. Adenomyosis, by contrast, is the presence of endometrial tissue within the uterine muscle wall. Historically thought to affect older parous women, adenomyosis is now recognized across a wider age spectrum and can coexist with endometriosis.

Both diagnoses share clinical features—pelvic pain, heavy periods, dyspareunia (pain with intercourse), and dysmenorrhea—but they can also produce atypical manifestations, including urinary urgency and bladder pain when disease lies adjacent to or invades structures near the bladder.

Prevalence and delay

Endometriosis affects an estimated one in ten women of reproductive age; the condition is underdiagnosed due to symptom variability and normalization of menstrual pain.
Diagnostic delay is substantial; many patients experience years—commonly five to ten—between symptom onset and definitive diagnosis. Laparoscopy with histopathologic confirmation remains the gold standard for diagnosis, which partly explains delays because clinicians must weigh surgical risks against uncertain benefits.
Adenomyosis prevalence estimates vary; routine imaging and greater clinical suspicion have revealed it in younger patients more often than previously thought.

The patient’s path reflected this complexity: after months of non-improving urinary symptoms and an MRI, she received an adenomyosis diagnosis. That finding complicated the clinical picture because adenomyosis can explain pelvic pain but is not an obvious cause of urinary urgency. Her pelvic floor therapist proposed investigating endometriosis specifically—advice that ultimately led to diagnostic laparoscopy and excision.

The Role and Limits of Imaging and Cystoscopy

Ultrasound, MRI, and endoscopic studies serve complementary roles, but none are perfect.

Transvaginal ultrasound: Often the first-line imaging tool. It reliably detects ovarian endometriomas and can suggest deep infiltrating disease, but superficial peritoneal endometriosis may be invisible.
Pelvic MRI: Better for mapping deep infiltrating disease and adenomyosis. MRI helped identify the patient’s adenomyosis, prompting surgical referral.
Cystoscopy: Direct visualization of the bladder lining can detect Hunner lesions (a distinct pathology in some IC patients) and signs of inflammation. In this case, cystoscopy revealed bladder inflammation but no definitive diagnosis. That outcome is common: the test can confirm bladder pathology but will not identify extravesical causes such as endometriosis just outside the bladder wall.

Clinicians must interpret imaging results in the broader clinical context. A normal ultrasound or MRI does not rule out endometriosis; conversely, radiographic adenomyosis does not exclude coexisting endometriosis. These conditions can coexist and overlap in ways that produce confusing symptom clusters.

Conservative Treatments: Where They Help and Where They Fall Short

Patients with pelvic pain typically encounter a stepwise therapeutic approach: analgesia, physiotherapy, bladder-directed therapies, and hormonal suppression, before surgical intervention is considered. That sequence has clinical logic but can prolong symptom burden if the chosen path doesn't address the root cause.

Antibiotics

Appropriate for confirmed bacterial infections. Repeated empiric antibiotic courses for unproven UTIs can delay alternate diagnoses and lead to collateral harms.

Bladder instillations

Delivered through a catheter, instillations introduce agents like heparin, lidocaine, or dimethyl sulfoxide directly into the bladder lining to reduce inflammation and relieve pain. They are a recognized therapy for certain forms of bladder pain syndrome.
In the story, a series of instillations was attempted without durable benefit. One procedural mishap—medication spilling due to incorrect catheter placement—illustrates that even established interventions have procedural risks and may be uncomfortable.

Pelvic floor physical therapy

Targets myofascial trigger points and dysfunctional pelvic muscle patterns. For a subset of patients, it is transformative.
The patient experienced temporary but repeatable symptom relief from weekly sessions, indicating a meaningful neuromuscular component that deserved attention alongside other investigations.

Hormonal therapies

Combined oral contraceptives, progestins, levonorgestrel IUDs, and GnRH agonists/antagonists (including newer therapies like elagolix) suppress menstruation and reduce endometriosis-associated inflammation.
Hormones are effective for many but carry trade-offs: mood changes, bone density considerations, and for some, exacerbation of depression. The patient described reluctance to return to the pill due to prior mood concerns and an existing psychiatric history. Shared decision-making is essential given the balance of symptom control and psychiatric side effects.

Analgesics and neuromodulation

NSAIDs, neuropathic agents (gabapentinoids), and neuromodulation techniques have roles depending on symptom drivers.

Conservative strategies should be parallel, not strictly linear. When a patient gains only fleeting relief, clinicians should escalate diagnostic evaluation rather than persisting with the same ineffective approaches.

Diagnostic Laparoscopy and Excision: Confirmation and Treatment

When symptoms persist and conservative measures fail or imaging raises suspicion, diagnostic laparoscopy becomes the decisive step. The procedure allows direct inspection of pelvic organs and removal (excision) of endometriotic lesions. Excision performed by a surgeon experienced in endometriosis surgery is both diagnostic and therapeutic.

Key points:

Laparoscopy can reveal lesions that are invisible on imaging. Superficial peritoneal implants often escape ultrasound and MRI detection.
Excision reduces pain and improves function for many patients. Complete excision requires surgical skill; fragmentary removal or ablation by inexperienced surgeons increases the likelihood of recurrence and persistent pain.
Histopathology may not always confirm endometriosis despite clear visual lesions, but experienced clinicians treat visualized lesions in the context of the full clinical picture.

In the case under review, laparoscopy found endometriosis, an unexpected cyst, two hernias, and the appendix—several of which were removed during the same operation. The discovery validated years of escalation and justified the surgical risk for that patient.

Fertility, Hormonal Choices and Tough Trade-offs

Endometriosis is associated with reduced fertility in some patients, although many conceive naturally. Adenomyosis has been linked to implantation difficulties and adverse pregnancy outcomes in select studies. Those findings create predictable anxiety for patients of reproductive age contemplating family planning.

Treatment decisions intersect with fertility goals:

Conservative surgery that excises endometriosis aims to reduce pain and may improve fertility, especially when ovarian endometriomas are present or tubular distortion exists.
Hormonal suppression can control symptoms but may delay conception while in use. Some fertility-preserving strategies combine surgical treatment with assisted reproductive technologies if surgery alone is insufficient.
For women who do not desire immediate pregnancy, fertility preservation strategies (egg freezing) are options. Yet ovarian stimulation protocols themselves can provoke hormonal flares of endometriosis for some patients.

The patient faced these dilemmas: she was 28, received a diagnosis that carries potential fertility implications, and considered egg freezing. Her gynecologist’s remark that a hysterectomy is often used to manage severe adenomyosis underscored a grim reality: for some people, ultimate definitive treatment involves removing the uterus, a life-altering choice. Open discussion about fertility priorities, risks and alternatives must happen up front.

The Emotional and Psychological Toll

Chronic pelvic pain and diagnostic uncertainty inflict psychological injury. Anxiety, depression, social withdrawal, and traumatic responses to invasive examinations or repeated procedural pain are common.

This patient experienced acute anxiety—using medication to endure flights, for example—and relied on social supports to cope. The repeated experience of being brushed off by clinicians amplified emotional distress. That pattern is not rare: women with chronic pelvic pain frequently report that dismissal by professionals contributes to their suffering as much as physical symptoms.

Mental health considerations should be integrated into care:

Screening for anxiety and depression, with referral to mental health professionals experienced in chronic pain, improves outcomes.
Trauma-informed care principles reduce re-traumatization during examinations and procedures.
Peer support and patient networks can mitigate isolation and provide practical navigation tips for complex care pathways.

Structural Failures: Why Diagnosis Is Delayed

Several systemic factors drive delayed or missed diagnoses:

Fragmented care pathways
- Pelvic pain spans specialties—primary care, emergency medicine, urology, gynecology, physiotherapy. Without coordinated multidisciplinary care, patients navigate siloed services that fail to integrate findings.
Limited specialist availability
- Experienced endometriosis surgeons are concentrated in academic centers and large metropolitan areas. Long wait times push patients toward less experienced practitioners or conservative management while disease progresses.
Gender biases and minimization
- Research and patient testimony consistently show that women's pain is more likely to be attributed to emotional causes or downplayed compared with men’s. This bias reduces diagnostic urgency.
Overreliance on single tests
- Normal labs or imaging are sometimes misread as definitive. Clinicians may stop investigating once initial tests are negative instead of reappraising the differential diagnosis.
Insurance and financial barriers
- Not all insurers cover multidisciplinary evaluations, specialized diagnostics, or long-term pelvic floor therapy. Out-of-pocket costs become prohibitive for many.

Each factor compounds the others. The patient’s experience—being treated differently while abroad, experiencing long waits, and seeing multiple clinicians offering conflicting advice—illustrates how structural problems become personal suffering.

Practical Strategies for Patients: How to Advocate and Where to Look

For anyone experiencing persistent pelvic or urinary symptoms, adopt a methodical approach that balances persistence with pragmatism.

Document symptoms

Keep a symptom diary noting frequency, triggers, menstrual phase, pain severity, bowel and urinary patterns, medication responses, and emotional impact. Objective documentation strengthens conversations with clinicians and helps reveal patterns.

Seek multidisciplinary evaluation

When possible, identify a center or team that offers coordinated gynecology, urology, pain medicine, pelvic floor physical therapy, and mental health support. These teams tend to diagnose and treat more efficiently.

Ask specific questions

If urinary symptoms persist despite negative cultures, ask about bladder pain syndrome, pelvic floor dysfunction, and the possibility of endometriosis or adenomyosis.
Request imaging targeted to suspected problems—transvaginal ultrasound for pelvic pathology, MRI for deep infiltrating disease—while recognizing imaging limits.

Consider pelvic floor physical therapy early

Even if other diagnoses are being explored, pelvic floor therapy can reduce symptoms and improve surgical outcomes if surgery becomes necessary.

Prepare for potential surgery

If laparoscopy is offered, discuss the surgeon’s experience with endometriosis excision, expected findings, potential concurrent procedures (appendectomy, hernia repair), and postoperative recovery plans.
Ask about histopathology protocols and follow-up plans for symptom recurrence.

Second opinions and surgeon selection

If a surgeon recommends only hormonal suppression for a patient with persistent disabling symptoms, it is reasonable to seek a second opinion, particularly from a surgeon with expertise in excision. Skill level matters for long-term outcomes.

Address mental health and safety

Seek psychological support that validates the pain experience and addresses procedural anxiety, trauma responses, and depression. This support is integral to holistic care.

Know your rights and resources

Patient advocacy organizations, online support groups, and registries of endometriosis-specialized surgeons can help navigate referrals and inform decision-making.

What Clinicians Should Change: Diagnostic Rigor and Respectful Care

Physicians and allied health professionals must adapt practice patterns to reduce barriers for patients with pelvic pain.

Adopt a broad, iterative differential

Negative initial tests should prompt reconsideration, not dismissal. Clinicians should document a plan for further evaluation when symptoms persist or recur.

Coordinate care proactively

Facilitating warm handoffs between urology, gynecology, pelvic floor therapy and pain medicine reduces duplication and patient burden.

Listen and validate

Acknowledging pain does not require diagnostic certainty. Validation protects the therapeutic relationship and reduces psychological harm.

Invest in training

Education about endometriosis, adenomyosis and pelvic floor disorders should be standard in front-line specialties that first encounter patients with pelvic pain.

Make shared decisions about fertility and hormones

Discuss the fertility implications of different treatments transparently. Incorporate reproductive endocrinology early when patients express fertility concerns.

Expand access

Systems-level efforts must increase availability of specialized services and ensure insurance coverage for multidisciplinary interventions, diagnostic laparoscopy, and pelvic floor therapy.

Outcomes and Uncertainties: What Patients Can Expect After Treatment

Surgery, when performed by an experienced team and coupled with rehabilitation, often decreases pain and improves quality of life. Expectation management matters: surgery is not a guaranteed cure. Endometriosis can recur, necessitating long-term surveillance and symptom management. Adenomyosis poses separate management challenges and may require uterine-sparing procedures or, in severe cases, hysterectomy.

Postoperative rehabilitation often includes:

Pelvic floor physical therapy to restore muscle balance and reduce residual pain.
Tailored hormonal strategies to suppress regrowth where appropriate.
Pain management plans that minimize opioid exposure while addressing neuropathic and nociceptive pain components.
Fertility planning when appropriate, with referral to reproductive specialists if conception is desired.

The patient at the center of this narrative experienced immediate validation after surgery and a period of physical recovery at home. She also faced ongoing uncertainty about long-term disease behavior and fertility—common themes for many patients.

Research and Future Directions

Research priorities should align with the needs of patients:

Biomarkers to enable noninvasive diagnosis of endometriosis.
Better imaging techniques to detect superficial peritoneal disease.
Comparative trials of excision versus ablation and of surgical strategies that preserve fertility.
Trials that integrate mental health and pelvic rehabilitation outcomes into standard endpoints.
Health services research focused on reducing diagnostic delay and testing models of multidisciplinary care delivery.

Therapeutics are evolving. Oral GnRH antagonists and novel agents targeting inflammatory pathways show promise in reducing pain while offering more flexible dosing strategies than older therapies. Progress in understanding the molecular drivers of the disease may open targeted treatments in the future.

The Cultural Dimension: Pain, Visibility and the Momentum for Change

The resonance of a public figure sharing a private medical ordeal matters because it shifts cultural recognition. When thousands of people reach out after a single account, it signals both the prevalence of the problem and the hunger for better care. Patients’ stories drive research priorities, inform clinician education, and create momentum for policy changes that improve access to multidisciplinary care.

The central indignity in many of these stories is not the complexity of the diseases but the commonplace dismissal of pain. Addressing that harm requires systemic commitments: better training, more integrated care, and policies that ensure patients are not forced to navigate a gauntlet of delays before receiving appropriate evaluation.

Putting It Together: A Roadmap for Patients and Providers

For patients:

Track symptoms systematically.
Seek care from teams with experience in pelvic pain when symptoms persist.
Use pelvic floor therapy as part of a broader diagnostic and therapeutic plan.
Ask for targeted imaging and consider diagnostic laparoscopy if symptoms continue despite conservative measures.

For providers:

Maintain a high index of suspicion for gynecologic causes of urinary and pelvic symptoms.
Coordinate referrals and avoid stopping the diagnostic process after a single negative test.
Listen, validate and incorporate mental health support into care pathways.
Recognize the limits of your specialty and collaborate across disciplines.

Together, these approaches reduce the time patients spend suffering and decrease the likelihood that women’s pain is normalized into silence.

FAQ

Q: What are the signs that urinary symptoms might not be a simple UTI? A: Red flags include persistent urgency and frequency despite negative urine cultures, recurrent symptoms after appropriate antibiotic therapy, bladder pain that does not respond to standard UTI treatment, pelvic pain that fluctuates with menstrual cycles, and associated symptoms such as pain during intercourse, heavy menstrual bleeding, or bowel-related pelvic pain. If such patterns emerge, clinicians should broaden the diagnostic search to include bladder pain syndrome, pelvic floor dysfunction, and gynecologic sources like endometriosis.

Q: How are endometriosis and adenomyosis different, and how do they overlap? A: Endometriosis involves tissue similar to the uterine lining growing outside the uterus; adenomyosis involves that tissue within the uterine muscle. Both produce pelvic pain and menstrual disturbances and can coexist. Endometriosis is diagnosed primarily through laparoscopy with visualization and excision; adenomyosis is often suggested by MRI or ultrasound but can be confirmed histologically when uterine tissue is evaluated, sometimes at the time of hysterectomy.

Q: Can endometriosis cause bladder symptoms? A: Yes. Endometriosis can affect areas near or on the bladder, producing urinary urgency, frequency, and pelvic pain. Deep infiltrating endometriosis that involves the vesicouterine or vesicovaginal septum is more likely to cause urinary symptoms. However, bladder symptoms are non-specific and may reflect bladder-centric conditions like BPS/IC or pelvic floor dysfunction rather than direct bladder involvement by endometriosis.

Q: When should a patient consider diagnostic laparoscopy? A: Consider laparoscopy when symptoms are persistent, significantly impair quality of life, and have not responded to conservative treatment—or when imaging strongly suggests endometriosis or another structural pelvic pathology. Discuss the benefits and risks with a surgeon experienced in endometriosis excision, and clarify expectations about potential findings and postoperative plans.

Q: Does surgery cure endometriosis? A: Surgery can substantially reduce pain and improve function in many patients, especially when performed as complete excision by an experienced surgeon. However, disease can recur; long-term management may include hormonal therapy, repeat surgery, and rehabilitative approaches. Outcome variability depends on disease extent, surgical completeness, and individual biology.

Q: What is the role of pelvic floor physical therapy? A: Pelvic floor therapy addresses muscular contributors to pelvic and urinary symptoms. It can reduce pain, improve bladder function, and enhance postoperative recovery. It should be part of a comprehensive plan and may be effective even when an underlying gynecologic cause is later identified.

Q: How should patients navigate concerns about fertility and treatment that affects hormones? A: Discuss fertility goals early. If future pregnancy is desired, involve a reproductive endocrinologist in the decision-making process. Some treatments that control pain—such as continuous hormonal suppression—can delay conception, while surgical excision may improve fertility for some patients. Fertility preservation options, such as egg freezing, can be considered when treatment plans risk delaying pregnancy.

Q: What can clinicians do immediately to reduce harm from diagnostic delay? A: Validate the patient’s pain, document a plan for escalation when initial tests are negative, coordinate with pelvic pain specialists, and prioritize timely diagnostic imaging or referral to an experienced surgeon when conservative measures fail. Integrate mental health support and pelvic rehabilitation early to mitigate the psychological impact of chronic pain.

Q: Are there resources for patients seeking specialized care? A: Patient advocacy groups, endometriosis foundations, and hospital registries often maintain lists of specialized centers and experienced surgeons. Peer support groups and patient networks can offer recommendations and practical guidance on choosing providers and preparing for consultations.

Q: How common is it for women to be dismissed when they seek help for pelvic pain? A: Studies and patient reports indicate a troubling pattern: women’s reports of pain are more likely to be minimized, and diagnostic delays for conditions like endometriosis average several years. This phenomenon has multifactorial roots—including gender bias, education gaps, and systemic care fragmentation—and demands institutional and professional responses.

Q: If someone is traveling or living abroad and has acute pelvic/urinary symptoms, what should they do? A: Seek prompt local care for acute concerns, especially if symptoms are severe or accompanied by fever, nausea, vomiting, or blood in the urine. Keep records of treatments and test results, and follow up with a trusted clinician at home. If hospitalized abroad, request written summaries and ask for copies of imaging to bring to follow-up appointments. If symptoms persist after returning home, insist upon comprehensive evaluation rather than repeated empiric antibiotics.

Pain that strays beyond simple explanations deserves tenacious, coordinated evaluation. Diagnostic clarity often requires looking beyond the first plausible answer and assembling a care team that treats both bodies and minds. The path from symptom onset to definitive diagnosis should be shorter and more humane than it too often is. For the many women walking that difficult road, validated experiences, clearer clinical pathways and broader access to specialized care are the most effective forms of relief.